Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Euroapi Gelecekteki Büyüme
Future kriter kontrolleri 0/6
Euroapi's revenue is forecast to decline at 0.2% per annum while its annual earnings are expected to grow at 73.1% per year. EPS is expected to grow by 75.9% per annum. Return on equity is forecast to be -0.9% in 3 years.
Anahtar bilgiler
73.1%
Kazanç büyüme oranı
75.9%
EPS büyüme oranı
| Pharmaceuticals kazanç büyümesi | 17.7% |
| Gelir büyüme oranı | -0.2% |
| Gelecekteki özkaynak getirisi | -0.9% |
| Analist kapsamı | Low |
| Son güncelleme | 06 Aug 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
There's No Escaping Euroapi S.A.'s (EPA:EAPI) Muted Revenues Despite A 32% Share Price Rise
Jul 29
Euroapi S.A. (EPA:EAPI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
May 24Euroapi (EPA:EAPI) Seems To Be Using A Lot Of Debt
Apr 10Little Excitement Around Euroapi S.A.'s (EPA:EAPI) Revenues As Shares Take 31% Pounding
Mar 03Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Mar 02A Look At The Fair Value Of Euroapi S.A. (EPA:EAPI)
Dec 21Analysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly Results
Aug 04Is Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?
Aug 02Euroapi S.A.'s (EPA:EAPI) Subdued P/S Might Signal An Opportunity
Jun 16An Intrinsic Calculation For Euroapi S.A. (EPA:EAPI) Suggests It's 37% Undervalued
Jan 25Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 38% Above Its Share Price
Oct 15Statutory Profit Doesn't Reflect How Good Euroapi's (EPA:EAPI) Earnings Are
Sep 09Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 930 | -31 | 14 | 86 | 5 |
| 12/31/2025 | 936 | -42 | -18 | 92 | 5 |
| 12/31/2024 | 918 | -80 | 79 | 176 | 5 |
| 6/30/2024 | 971 | -287 | -39 | 115 | N/A |
| 3/31/2024 | 995 | -238 | -100 | 60 | N/A |
| 12/31/2023 | 1,019 | -190 | -161 | 5 | N/A |
| 9/30/2023 | 1,006 | -79 | -133 | 4 | N/A |
| 6/30/2023 | 994 | 31 | -105 | 3 | N/A |
| 3/31/2023 | 987 | 8 | -87 | 24 | N/A |
| 12/31/2022 | 981 | -15 | -69 | 45 | N/A |
| 9/30/2022 | 962 | -3 | -99 | 46 | N/A |
| 6/30/2022 | 944 | 10 | -129 | 47 | N/A |
| 3/31/2022 | 918 | 1 | -96 | 59 | N/A |
| 12/31/2021 | 893 | -8 | -64 | 72 | N/A |
| 12/31/2020 | 945 | -6 | 8 | 97 | N/A |
| 12/31/2019 | 916 | 3 | -47 | 35 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: EAPI is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: EAPI is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: EAPI is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: EAPI's revenue is expected to decline over the next 3 years (-0.2% per year).
Yüksek Büyüme Geliri: EAPI's revenue is forecast to decline over the next 3 years (-0.2% per year).
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: EAPI is forecast to be unprofitable in 3 years.